2022 Annual Scientific Meeting of the Korean Society of Heart Failure

Presentation Guideline

Abstract > Presentation Guideline

On-site Presentation Requirement

- All oral presenters are required to attend and present in person. Remote presentations will not be permitted.

Presentation Duration

Oral Presentation & HF Research Award Young Investigator Award Session

- Total time: 10 minutes

  • 7 minutes for the presentation
  • 3 minutes for Q&A

- Total time: 9 minutes

  • 6 minutes for the presentation
  • 3 minutes for Q&A

Language

- All presentations must be conducted in English, the official language of instruction for Heart Failure Seoul 2025
  with CTC Asia 2025.

Presentation File Preparation

  • - Prepare your presentation in English using MS PowerPoint (.pptx) with a 16:9 aspect ratio.
  • - The number of slides is strictly limited to 15 slides.
  • - Include your Disclosure Information on the first slide; this will be displayed before your presentation begins.
  • - All presenters must visit the Preview Room to check and upload their presentation file before the session starts.
  • - PowerPoint files must be submitted in advance at the Preview Room; on-site submission is mandatory.

Heart Failure Seoul 2025 PowerPoint Template

General Information

  • - All presenters must complete registration for Heart Failure Seoul 2025 with CTC Asia 2025.
  • - If registration is not completed, the abstract will be withdrawn and not included in the abstract book.
  • - The Presenting Author must deliver the presentation in person during the assigned session.
  • - To withdraw your abstract, please contact the secretariat at info@kshfmeeting.org.

Sessions Information

Friday, September 12, 2025, Room C
09:00-10:20 Oral Presentation & HF Research Award Jin Ok Jeong (Chungnam National Univ., Korea)
Kye Hun Kim (Chonnam National Univ., Korea)
09:00-09:10 Deep Learning-Based Modeling of Gender-Affirming Hormone Therapy and Circulating miRNA Signatures to Predict Heart Failure Risk in Transgender Individuals Rifaldy Fajar (IMCDS-BRF, Indonesia)
09:10-09:20 Clinical Implications of Significant Tricuspid Regurgitation in LVAD Recipients: Prognostic Relevance and Postoperative Trajectory Heayoung Shin (Sungkyunkwan Univ., Korea)
09:20-09:30 Immunopathologic Features of Biopsy-Confirmed Myocarditis After COVID-19 mRNA Vaccination Eui-Soon Kim (The Catholic Univ., Korea)
09:30-09:40 Comparative Prognostic Value of Frailty Assessment Tools in Older Patients with Heart Failure: A Post-hoc Analysis of FRAGILE-HF Yoshiaki Ikeda (Juntendo Univ., Japan)
09:40-09:50 High versus Low Positive End-Expiratory Pressure in Mechanically Ventilated Patients with Acute Heart Failure Min-Seok Kim (Ulsan Univ., Korea)
09:50-10:00 Relationship Between Left Ventricular Reverse Remodeling and Guideline-Directed Medical Therapy Intensity Score in De Novo Heart Failure with Reduced Ejection Fraction Patients: Insight from TRANS-HF trial Taeil Yang (Gachon Univ., Korea)
10:00-10:10 Real-world eligibility of finerenone in patients with heart failure: Insights from the Korean heart failure III (KorHF III) registry Moojun Kim (Yonsei Univ., Korea)
10:10-10:20 Impact of Cardiac Contractility Modulation on Reverse Remodeling and Clinical Outcomes in Heart Failure: A Systematic Review and Meta-Analysis David Yobel (Ngoerah Hospital, Indonesia)
Friday, September 12, 2025, Room C
10:40-12:01 Young Investigator Award Session Mi-Seung Shin (Gachon Univ., Korea)
Seonghoon Choi (Hallym Univ., Korea)
10:40-10:49 Modification of Stress Echocardiography Criteria in HFA-PEFF Algorithm: Based on the hemodynamic study Ji Hyun Cha (Sungkyunkwan Univ., Korea)
10:49-10:58 Respiratory Sarcopenia as a Novel and Powerful Predictor of Mortality in Older Patients Hospitalized for Heart Failure: Findings from the SONIC-HF Study Taisuke Nakade (Juntendo Univ., Japan)
10:58-11:07 Development of Multimodal Digital Stethoscope System for Self-Monitoring of Heart Failure Status Qun Wei (Keimyung Univ., Korea)
11:07-11:16 Transcriptomic and Network-Based Profiling Reveals Key Molecular Pathways and Therapeutic Targets in Dilated Cardiomyopathy Nadyatul Husna (Reksodiwiryo Military Hospital, Padang, Indonesia)
11:16-11:25 Imagenetics in Non-Ischemic Dilated Cardiomyopathy : Linking Cardiac Magnetic Resonance Imaging Phenotypes to Genotypic Signatures Jooyeon Lee (Yonsei Univ., Korea)
11:25-11:34 Eligibility for FINEARTS-HF in a real-world nationwide cohort with heart failure with mildly reduced or preserved ejection fraction Benedikt Beer (Karolinska Institutet, Sweden)
11:34-11:43 Impact of a Discharge Checklist on Guideline-Directed Medical Therapy Adherence and Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: A Comparative Observational Study Eunjoung Choi (Korea Univ., Korea)
11:43-11:52 Modeling HeartBrain Crosstalk in Heart Failure under SGLT2 Inhibition: A Digital Twin Simulation Using Transcriptomics and LigandReceptor Networks Javad Alizargar (National Taipei Univ., Taiwan)
11:52-12:01 Distinct inflammasome and type I interferon pathways drive divergent immune dynamics in vaccine-associated and conventional myocarditis Yongjae Lee (KAIST, Korea)
Abstract